Cargando…

OR05-02 Silencing Of Adenylosuccinate Lyase Impairs Growth And Perturbs Mitochondrial Function Of Endocrine Therapy Resistant Breast Cancer Cells

Disclosure: A.K. Yadav: None. L. Jin: None. R. Clarke: None. S. Sengupta: None. The estrogen receptor positive (ER+) subtype comprises of ∼80% of all breast cancers and is the major contributor to cancer related deaths in women. While ER+ breast cancers respond to treatment with endocrine therapies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yadav, Anil K, Jin, Lu, Clarke, Robert, Sengupta, Surojeet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Tumor Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553865/ http://dx.doi.org/10.1210/jendso/bvad114.2188

Ejemplares similares

RF05 | PSUN341 Role of sirtuins in breast cancer cells response to Fulvestrant
por: Sengupta, Surojeet, et al.
Publicado: (2022)

THU548 The Role Of Sirtuin 3 In Endocrine Therapy Resistant Breast Cancer Cells Response To Fulvestrant
por: de Oliveira, Karla Andrade, et al.
Publicado: (2023)

Adenylosuccinate lyase deficiency
por: Jurecka, Agnieszka, et al.
Publicado: (2014)

Adenylosuccinate lyase deficiency affects neurobehavior via perturbations to tyramine signaling in Caenorhabditis elegans
por: Moro, Corinna A., et al.
Publicado: (2023)

MRI findings of hypomyelination in adenylosuccinate lyase deficiency
por: Kayfan, Samar, et al.
Publicado: (2018)

Molecular comparison of Neanderthal and Modern Human adenylosuccinate lyase
por: Van Laer, Bart, et al.
Publicado: (2018)

Clinical and molecular characterization of patients with adenylosuccinate lyase deficiency
por: Mastrogiorgio, Gerarda, et al.
Publicado: (2021)

Prevalence of adenylosuccinate lyase deficiency based on aggregated exome data
por: Ferreira, Carlos R.
Publicado: (2017)

OR05-02 The IGFBP-3/IGFBP-3 Receptor Axis Is a New Therapeutic Target for Triple Negative Breast Cancer
por: Cai, Qing, et al.
Publicado: (2020)

RF05 | PSUN364 A Rare Case of Bilateral Parathyroid Carcinoma in the Setting of Multiple Endocrine Neoplasia Type 1
por: Kesavan Chary, Priyanka, et al.
Publicado: (2022)

Diagnosis of adenylosuccinate lyase deficiency by metabolomic profiling in plasma reveals a phenotypic spectrum
por: Donti, Taraka R., et al.
Publicado: (2016)

Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer
por: Zurlo, Giada, et al.
Publicado: (2019)

OR05-05 A Novel Model Of Prostate Cancer Suggests Enzalutamide Functions Through The Immune System To Diminish Castration Resistant And Metastatic Growth
por: Kregel, Steven
Publicado: (2023)

OR05-05 Lethal ERα-Dependent Hyperactivation of the Unfolded Protein Response Induces Complete Regression Without Recurrence of Primary and Metastatic Breast Cancer
por: Duraki, Darjan, et al.
Publicado: (2020)

Very mild isolated intellectual disability caused by adenylosuccinate lyase deficiency: a new phenotype()
por: Macchiaiolo, Marina, et al.
Publicado: (2020)

OR05-01 Small Heterodimer Partner Modulates Antigen Presenting Myeloid Cells to Impair Regulatory T Cell Expansion, Promoting Anti-Tumor Immunity in Models of Breast Cancer
por: Shahoei, Sayyed Hamed, et al.
Publicado: (2020)

Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis
por: Taha-Mehlitz, Stephanie, et al.
Publicado: (2021)

OR05-03 Treatment Of Parathyroid Neoplasia By Pharmacologic cdk4/6 Inhibition
por: Costa-Guda, Jessica, et al.
Publicado: (2023)

Recurrent Pheochromocytoma, as Component of Multiple Endocrine Neoplasia
por: Dominguez, Hydelene Beray, et al.
Publicado: (2021)

SUN-128 Impaired Fasting Glucose Is Associated with Insulin Resistance in Patients with Germline Mutations in the Multiple Endocrine Neoplasia Type 1 (MEN1) Gene
por: Bansal, Rashika, et al.
Publicado: (2020)

Broadening phenotype of adenylosuccinate lyase deficiency: A novel clinical pattern resembling neuronal ceroid lipofuscinosis
por: Mastrangelo, Mario, et al.
Publicado: (2019)

Novel mutations in ADSL for Adenylosuccinate Lyase Deficiency identified by the combination of Trio-WES and constantly updated guidelines
por: Mao, Xiao, et al.
Publicado: (2017)

Carcinogenic effect of adenylosuccinate lyase (ADSL) in prostate cancer development and progression through the cell cycle pathway
por: Liao, Jinling, et al.
Publicado: (2021)

OR05-06 The Androgen Receptor Is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer
por: Hickey, Theresa E, et al.
Publicado: (2020)

OR16-05 25-Hydroxycholesterol Mediates The Effects Of Dyslipidemia On Triple Negative Breast Cancer Metastasis
por: Etella, Abora, et al.
Publicado: (2023)

A Rare Presentation of Multiple Endocrine Neoplasia Type 1
por: Pradeep, Pallavi, et al.
Publicado: (2021)

RF05 | PSUN365 Insulinoma: A Case Report of a Rare Functioning Neuroendocrine Tumor
por: Pescador, Antonio, et al.
Publicado: (2022)

OR16-02 Histone ADP-Ribosylation Site Mutations As Oncogenic Drivers In Breast And Ovarian Cancers
por: Huang, Dan, et al.
Publicado: (2023)

OR05-06 Histone Deacetylase Inhibitor, Panobinostat, In Combination With A Smac-mimetic For The Treatment Of Ovarian Granulosa Cell Tumours
por: Chu, Simon, et al.
Publicado: (2023)

MON-LB053 Involvement of Stromal Age in Breasts Cancer Endocrine Response
por: Cavalier, Maryn, et al.
Publicado: (2019)

SAT-LB310 A Mysterious Multiple Endocrine Neoplasia (MEN) Like Syndrome
por: Soe, Myat Han, et al.
Publicado: (2020)

MON-906 MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A: Familiar Case Report
por: Sousa, Barbara K P, et al.
Publicado: (2020)

MON-922 Multiple Endocrine Neoplasia Type 1- A Clarion Call for Clarity
por: Hashmi, Hiba, et al.
Publicado: (2020)

Thymoma and Not Just Thymic Carcinoid Can Be Associated With Multiple Endocrine Neoplasia Type 1
por: Graf, Akua, et al.
Publicado: (2021)

SUN-LB26 Radioligand Theranostics of Endocrine-Related Cancers; A New, Revolutionary Approach
por: Harris, Alan G, et al.
Publicado: (2020)

SUN-912 The Rare Men of Mississippi Complications in the Diagnosis of Multiple Endocrine Neoplasia Type 1
por: Rashid, Hytham, et al.
Publicado: (2020)

SUN-127 Diagnostic Challenges Associated with the Rising Incidence of Endocrine Toxicity in the Era of Combination Immunotherapy
por: Galligan, Anna, et al.
Publicado: (2020)

SAT-119 Targeting Glutamate Metabolism and Signaling in ER+, Endocrine Therapy-Resistant Breast Cancer
por: Olukoya, Ayodeji O, et al.
Publicado: (2020)

ODP538 A Case of Multiple Endocrine Neoplasia Type 2A with Malignant Paraganglioma
por: Ozawa, Atsushi, et al.
Publicado: (2022)

OR16-5 Riluzole suppresses growth and enhances response to endocrine therapy in ER+ breast cancer
por: Bahnassy, Shaymaa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2t0vs7ann8pjtcunck0oa8fs21